cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2002; 40:573-574
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellstrom, H. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hellstrom, H. R.

LETTERS TO THE EDITOR

Coronary microvascular spasm in patients with vasospastic angina

H. Richard Hellstrom, MDa

a SUNY Upstate Medical University,Room 2106 Weiskotten Hall,750 East Adams Street.Syracuse, New York 13210E-mail: hellstrr@mail.upstate.edu, USA,


I read with interest the study by Sun et al. (1), which showed that 25.5% of patients with vasospastic angina developed myocardial ischemia with submaximal doses of intracoronary acetylcholine; angina was unassociated with spasm of epicardial arteries and was attributed to microvascular spasm. Remaining patients developed myocardial ischemia only when epicardial spasm occurred, and Sun et al. (1) did not rule out the coexistence of microvascular spasm in these cases.

The Sun et al. (1) study is in keeping with the spasm of resistance vessel (S-RV) concept of ischemic heart disease (IHD) (2–5), which asserts that S-RV induces symptoms in all syndromes of IHD and in cases with and without coronary artery disease (CAD). S-RV is used instead of microvascular spasm, as spasm probably occurs in vessels designed to undergo vasomotion to maintain vascular homeostasis. The concept asserts that risk factors act additively and operate by favoring S-RV, and there is evidence that major risk factors favor S-RV—including hypercholesterolemia and CAD (2,4,5). The concept avers that stenotic CAD favors S-RV through ischemia-induced S-RV, and there is abundant evidence that significant ischemia favors S-RV (2,5). As an example, effort angina is attributed to stenotic CAD plus exertion, which together cause sufficient ischemia to trigger ischemia-induced S-RV and clinical symptoms.

Interest in S-RV in IHD has been limited mainly to vasospastic angina, as these cases are unassociated with stenotic CAD. But there is evidence for S-RV in stable angina (3,5), and relative insufficiency probably is an invalid mechanism; cholesterol- and stress-reduction significantly improved angina in a month’s time (6), long before CAD could be improved—a finding incompatible with classic relative insufficiency (3,5). Favorable to the concept, cholesterol reduction favors vasodilation and can improve vasodilation in one month (7) and, as stress can cause S-RV (3), stress-reduction reasonably is vasodilative. Also, while plaque rupture/thromboses are the accepted mechanisms of acute coronary syndromes, a recent analysis showed significant faults with this mechanism (5). For example, studies of infarction showing rising incidences of thromboses over time are incompatible with primary thromboses. If thromboses cause infarction, how can their incidence increase over time? And recognition of S-RV during ischemic episodes in unstable angina (8) is consistent with the S-RV cause of this angina.

The S-RV concept offers an explanation for the only occasional occurrence of vasospastic angina, and a viable explanation should help establish the reasonableness of the concept. As vasospastic angina is unassociated with CAD, this major vasoconstrictive force is absent, and angina occurs only when there are high levels of other risk factors as stress, gender and genetic factors, etc.—which occur only occasionally. In IHD associated with CAD, symptoms are attributed to the risk factor of CAD plus other risk factors such as stress; consistent with this, induced stress can cause myocardial ischemia in individuals with stable angina (9,10). Also, absence of IHD in many individuals with severe CAD is explained by the relative absence of other risk factors such as stress.

Although considerable evidence supports the standard position, there appears to be sufficient contravening evidence for the S-RV concept to prompt a comprehensive review of its positions.


    References
 Top
 References
 

  1. Sun H, Mohr M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Col Cardiol. 2002;39:847–851[Abstract/Free Full Text]
  2. Hellstrom HR. The spasm of resistance vessel concept of ischemic heart disease and other ischemic diseases. Med Hypotheses. 1990;33:31–41[CrossRef][Medline]
  3. Hellstrom HR. Evidence in support of the spasm of resistance vessel concept of ischemic heart disease: an update in 1993. Med Hypotheses. 1993;41:11–22[CrossRef][Medline]
  4. Hellstrom HR. New evidence for the spasm of resistance vessel concept of ischemic diseases. Med Hypotheses. 1999;53:200–209[CrossRef][Medline]
  5. Hellstrom HR. Occlusions of epicardial arteries might not directly induce symptoms in ischemic heart disease. Med Hypotheses. 1999;53:533–542[CrossRef][Medline]
  6. Ornish D, Scherwitz LW, Doody RS, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983;249:54–59[Abstract]
  7. O’Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997;95:1126–1131[Abstract/Free Full Text]
  8. Marzilli M, Sambuceti G, Fedele S, L’Abbate A. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol. 2000;35:327–337[Abstract/Free Full Text]
  9. Deanfield JE, Shea M, Kensett M, et al. Silent myocardial ischaemia due to mental stress. Lancet. 1984;2:1001–1005[Medline]
  10. Giubbini R, Galli M, Campini R, Bosimini E, Bencivelli W, Tavazzi L. Effects of mental stress on myocardial perfusion in patients with ischemic heart disease. Circulation. 1991;83(Suppl II):II100–107




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellstrom, H. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hellstrom, H. R.

 
  cardiology careers collections past issues search home